dr. M.C.J.M. (Miriam) Sturkenboom

Associate Professor

  • Department of Biostatistics and Research Support
  • Julius Center Research Program Cardiovascular Epidemiology

dr. M.C.J.M. (Miriam) Sturkenboom


Miriam Sturkenboom is pharmacoepidemiologist. She is professor in Observational Data Analysis and worked until 2017 at the department of Medical Informatics of the Erasmus University Medical Center in the Netherlands. Mid 2017 she transferred to the Global Health Group at the Julius Center at University Medical Center Utrecht in the Netherlands. She has a PhD from the Faculty of Mathematics and Physics in Groningen (cum laude), a pharmacy degree from the same University and a Master in Epidemiology from the Harvard School of Public Health. She is past president of the International Society for Pharmacoepidemiology. She serves as expert to EMA, FDA, WHO and many other organizations

Her research interests focus on transforming real world data into real world evidence on drug use, effectiveness and safety in vulnerable populations (children, pregnancy and elderly). Her research focuses on the creation of international ecosystems that allow for big data mining, pooling and analysis to learn about the use and effects of drugs after marketing. These infrastructures have been tested and used as prototypes in many distributed networks in projects funded by the European Commission, the Innovative Medicines Initiative, the European Medicines Agency, ECDC, and also privately funded projects that she coordinate(d/s). She was coordinator of the IMI funded ADVANCE public private collaboration, aiming to establish a tested system for the monitoring of benefits and risks of vaccines. She is coordinator of the IMI-funded ConcepTION project, building an ecosystem to assess drugs safety in pregnancy and lactation. She is member of the WHO Global Advisory Committee for Vaccine Saftey. In terms of quantitative research outputs: she supervises/d more than 50 PhD students, has more than 400 peer reviewed papers in the area of pharmacovigilance, pharmacoepidemiology and medical informatics and an h-index of 74.

Research Output (100)

Impact of risk minimisation measures on the use of strontium ranelate in Europe:a multi-national cohort study in 5 EU countries by the EU-ADR Alliance

Berencsi K, Sami A, Ali M S, Marinier K, Deltour N, Perez-Guthann S, Pedersen L, Rijnbeek P, Van der Lei J, Lapi F, Simonetti M, Reyes C, Sturkenboom M C J M, Prieto-Alhambra D apr 2020, In: Osteoporosis International. 31 , p. 721-755 35 p.

Systematic Review and Meta-analysis of Postlicensure Observational Studies on Human Papillomavirus Vaccination and Autoimmune and Other Rare Adverse Events

Willame Corinne, Gadroen Kartini, Bramer Wichor, Weibel Daniel, Sturkenboom Miriam apr 2020, In: The Pediatric infectious disease journal. 39 , p. 287-293 7 p.

Fatal outcomes following immunization errors as reported to the EudraVigilance:A case series

Hoeve Christina E, Gadroen Kartini, Kwa Marcel S G, van Haren Anja, Sturkenboom Miriam C J M, Straus Sabine M J M 5 mrt 2020, In: Vaccine. 38 , p. 3086-3095 10 p.

Descriptive analysis of postmarket surveillance data for hip implants

Pane Josep, Verhamme Katia M C, Rebollo Irene, Sturkenboom Miriam C J M 3 mrt 2020, In: Pharmacoepidemiology and Drug Safety. 29 , p. 380-387 8 p.

Incidence, risk factors and re-exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study

Engelkes Marjolein, Baan Esme J, de Ridder Maria A J, Svensson Elisabeth, Prieto-Alhambra Daniel, Lapi Francesco, Giaquinto Carlo, Picelli Gino, Boudiaf Nada, Albers Frank, Evitt Lee A, Cockle Sarah, Bradford Eric, Van Dyke Melissa K, Suruki Robert, Rijnbeek Peter, Sturkenboom Miriam C J M, Janssens Hettie M, Verhamme Katia M C 1 mrt 2020, In: Pediatric Allergy and Immunology. 31 , p. 496-505 10 p.

Correction to::Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance (Osteoporosis International, (2019), 10.1007/s00198-019-05181-6)

Berencsi K, Sami A, Ali M S, Marinier K, Deltour N, Perez-Gutthann S, Pedersen L, Rijnbeek P, Van der Lei J, Lapi F, Simonetti M, Reyes C, Sturkenboom M C J M, Prieto-Alhambra D 5 feb 2020, In: Osteoporosis International. 31 , p. 799 1 p.

Big Data in the Assessment of Pediatric Medication Safety

McMahon Ann W, Cooper William O, Brown Jeffrey S, Carleton Bruce, Doshi-Velez Finale, Kohane Isaac, Goldman Jennifer L, Hoffman Mark A, Kamaleswaran Rishikesan, Sakiyama Michiyo, Sekine Shohko, Sturkenboom Miriam C J M, Turner Mark A, Califf Robert M feb 2020, In: Pediatrics. 145 9 p.

Obstetrics- versus non-obstetrics-based chart abstractor impact on ability to classify GAIA outcome definitions for potential AEFI in pregnant women and their infants in preparation for use in maternal immunization studies

Kachikis A., Eckert L. O., Munoz F. M., Sienas L., Simon R., Sturkenboom M. C. J. M., Dodd C. N., Jones C. E., Schlaudecker E. P., Khalil A., Yildirim I., Wilcox C. R., Heath P. T., Buttery J., Black S. dec 2019, In: American Journal of Obstetrics and Gynecology. 221 , p. 692-693

ADVANCE:Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases

Bollaerts Kaatje, de Smedt Tom, McGee Chris, Emborg Hanne-Dorthe, Villa Marco, Alexandridou Maria, Duarte-Salles Talita, Gini Rosa, Bartolini Claudia, de Lusignan Simon, Tin Tin Htar Myint, Titievsky Lina, Sturkenboom Miriam, Bauchau Vincent 31 okt 2019, In: Vaccine. 38 , p. B76-B83 8 p.

ADVANCE system testing:Can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example

Emborg Hanne-Dorthe, Kahlert Johnny, Braeye Toon, Bauwens Jorgen, Bollaerts Kaatje, Danieli Giorgia, Duarte-Salles Talita, Glismann Steffen, Huerta Consuelo, de Lusignan Simon, Martin Elisa, McGee Chris, Correa Ana, Tramontan Lara, Weibel Daniel, Sturkenboom Miriam 31 okt 2019, In: Vaccine. 38 , p. B22-B30

All Research Output (100)